EUVIMEDEUVIMED entdecken
Crossref

Sonodynamic Therapy by Reactive Oxygen Species Generation-Responsive Pseudo-Semiconducting Polymer Nanoparticles Combined with a Fibroblast Growth Factor Receptor Inhibitor for Enhancing Immunotherapy in Bladder Cancer

Chao Yang, Wenkuan Wang, Yunhao Gao, Lu Yin, Kehao Pan, Dong Chen, Feiya Yang, Nianzeng Xing iD

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.4c20545 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Chao Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology/State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Reactive Oxygen Species, Nanoparticles, Immunotherapy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Capital Health Research and Development of Special, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsReactive Oxygen SpeciesNanoparticlesImmunotherapyPolymersThiophenesPyrazolesAntineoplastic AgentsUltrasonic TherapyAnimalsMiceHumansCell Line, TumorReceptor, Fibroblast Growth Factor, Type 3Mice, Inbred BALB CFemaleQuinoxalines

Stichwörter der Autor:innen

FGFRbladder cancerimmunotherapynanoparticlesonodynamic therapy

Substanzen

Reactive Oxygen SpeciesPolymerserdafitinibThiophenesPyrazolesAntineoplastic AgentsReceptor, Fibroblast Growth Factor, Type 3Quinoxalines

Autor:innen und Institutionen

  • Department of Urology/State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College…

ORCID-Profile: Nianzeng Xing

Förderung

  • Ministry of Science and Technology of the People's Republic of China
  • Capital Health Research and Development of Special
  • Chinese Academy of Medical Sciences Initiative for Innovative Medicine

Zitieren

APA

Yang, C., Wang, W., Gao, Y., Yin, L., Pan, K., Chen, D., Yang, F., & Xing, N. (2025). Sonodynamic Therapy by Reactive Oxygen Species Generation-Responsive Pseudo-Semiconducting Polymer Nanoparticles Combined with a Fibroblast Growth Factor Receptor Inhibitor for Enhancing Immunotherapy in Bladder Cancer. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.4c20545

Vancouver

Yang C, Wang W, Gao Y, Yin L, Pan K, Chen D, et al. Sonodynamic Therapy by Reactive Oxygen Species Generation-Responsive Pseudo-Semiconducting Polymer Nanoparticles Combined with a Fibroblast Growth Factor Receptor Inhibitor for Enhancing Immunotherapy in Bladder Cancer. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.4c20545

BibTeX
@article{Yang2025,
  author = {Yang, Chao and Wang, Wenkuan and Gao, Yunhao and Yin, Lu and Pan, Kehao and Chen, Dong and Yang, Feiya and Xing, Nianzeng},
  title = {Sonodynamic Therapy by Reactive Oxygen Species Generation-Responsive Pseudo-Semiconducting Polymer Nanoparticles Combined with a Fibroblast Growth Factor Receptor Inhibitor for Enhancing Immunotherapy in Bladder Cancer},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.4c20545}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche